Press monitoring
The Midas Bug -- the bacterial alchemy of gold
21.8.2006 | Press monitoring
Bacteria play an important role in the formation of gold nuggets in Australia according to new research published this month in the international journal Science.
New insights into mouth cancers
21.8.2006 | Press monitoring
LONDON (Reuters) - Mouth cancer develops in two distinct ways which determine the seriousness of the disease, scientists said on Tuesday, a finding that could lead to new ways of preventing and treating it.
Cangene awarded contract to supply anti-anthrax drug to U.S. government
21.8.2006 | Press monitoring
WINNIPEG (CP) - Drug maker Cangene Corp. (TSX:CNJ) has won a $143-million US contract from the U.S. government to supply an anti-anthrax drug that would be used to fight a bioterrorist attack.
APCI microchip brings GC and MS closer together
20.8.2006 | Press monitoring
Finnish chemists have developed an atmospheric pressure chemical ionization (APCI) microchip for linking gas chromatography (GC) and mass spectrometry (MS), offering the potential for more detailed analyses of small biomolecules..
HIV drugs may help protect women
19.8.2006 | Press monitoring
TORONTO (Reuters) - Doctors are finding new uses for HIV drugs, with one study showing they might safely protect women at high risk of infection and a second showing that people can safely skip the most toxic pills.
Scientists look at worms for electronic wine nose
19.8.2006 | Press monitoring
CANBERRA (Reuters) - Australian scientists have begun looking at smell sensors in worms and insects to help them build an electronic "cybernose" they hope will one day be capable of measuring aromas and flavors in wine.
Diagnosing Meningitis with NMR
19.8.2006 | Press monitoring
Researchers have adapted chemistrys sophisticated proton nuclear magnetic resonance (NMR) technology to diagnose bacterial meningitis, a potentially fatal infection of the brain.
Study: Botulinum toxin heals facial scars
19.8.2006 | Press monitoring
U.S. scientists say treating facial wounds during the early healing phase with botulinum toxin -- Botox -- improves the later appearance of scars.
U-M professor’s nanotechnology company secures $30 million investment
19.8.2006 | Press monitoring
ANN ARBOR, Mich.—NanoBio Corporation, a company founded by Dr. James R. Baker, Jr., the Ruth Dow Doan Professor of Biologic Nanotechnology at the University of Michigan, has secured $30 million in funding from Perseus, L.L.C., a leading private equity fund management company headquartered in Washington, D.C.
